realtim
rt
pcr
revers
transcript
rt
pcr
techniqu
rapid
versatil
diagnost
procedur
broadli
use
clinic
virolog
mostli
consid
diagnost
gold
standard
monitor
rtpcr
rtrtpcr
assay
valid
result
reli
use
relev
extern
intern
control
ec
ic
commerci
kit
includ
control
system
increasingli
improv
molecular
diagnosi
number
pathogen
hiv
hepat
virus
influenza
virus
etc
howev
one
main
strength
rtpcr
versatil
provid
opportun
setup
inhous
protocol
specif
pathogen
scientif
literatur
includ
impress
number
home
made
assay
variou
viral
agent
whilst
commerci
kit
includ
ic
ec
allow
accur
valid
result
home
made
test
frequent
perform
absenc
ic
therefor
without
possibl
individu
monitor
diagnost
reaction
exampl
detect
technic
error
pcr
amplif
inhibitor
intrins
imposs
ec
use
addit
ec
usual
undistinguish
nativ
genom
object
develop
test
larg
number
clinic
sampl
bacteriophagebas
ic
system
suitabl
standard
laboratori
medic
virolog
present
result
obtain
use
bacteriophag
ic
routinebas
evalu
includ
clinic
specimen
repres
type
sampl
submit
pcr
detect
select
virus
includ
dna
virus
herpesvirida
jc
bk
virus
parvoviru
adenovirus
rna
virus
enteroviru
influenza
viru
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
toscana
viru
west
nile
viru
lymphocyt
choriomeningitidi
viru
dengu
viru
chikungunya
viru
import
criteria
design
ec
includ
possibl
use
quantifi
semi
quantifi
control
order
manag
detect
level
diagnost
test
use
ii
possibl
distinguish
amplicon
obtain
ec
obtain
detect
pathogen
order
detect
fals
posit
due
accident
amplif
ec
iii
use
relev
nucleic
acid
ie
rna
dna
molecul
rna
dna
virus
respect
simpl
protocol
prepar
plasmid
dna
synthet
rna
quantifi
control
describ
support
inform
schematis
figur
control
includ
specif
sequenc
hybridis
detect
primer
probe
also
exogen
sequenc
detect
specif
probe
cleavabl
restrict
enzym
criteria
address
regard
ic
monitor
step
diagnost
procedur
extract
rt
pcr
ii
amen
dna
rna
virus
iii
reli
detect
system
specif
phage
avoid
complex
molecular
construct
iv
usabl
either
simplex
multiplex
format
onestep
twostep
rtpcr
reaction
use
freezedri
e
coli
enterobacteria
phage
enterobacteria
phage
obtain
american
type
cultur
collect
atcc
ref
respect
protocol
real
time
pcr
detect
phage
ta
elabor
variou
format
describ
support
inform
briefli
primer
probe
target
phage
ccatccatagagaaaatatcagaacga
taaataattcctcttttcccagcg
vicaaccagtaatttcatctgcttctgatgtgaggctamra
phage
ctctgagagcggctctattggt
gttccctacaacgagcctaaattc
victcagacacgcggtccgctataacgatamra
design
genom
sequenc
optimis
oligonucleotid
concentr
primer
probe
detect
assay
suspens
phage
use
spike
clinic
sampl
phage
dilut
provid
similar
level
detect
rtpcr
follow
format
use
influenc
spike
perform
viral
nucleic
acid
extract
evalu
compar
detect
enteroviru
echoviru
cytomegaloviru
cmv
serial
dilut
cell
cultur
supernat
spike
spike
phage
see
support
inform
similarli
influenc
spike
sensit
rtpcr
detect
evalu
compar
detect
enteroviru
ev
cmv
serial
dilut
cell
cultur
supernat
media
seri
posit
clinic
sampl
spike
mix
either
twostep
onestep
rtpcr
format
see
support
inform
januari
may
total
clinic
specimen
receiv
virolog
laboratori
public
hospit
marseil
demand
pcr
detect
least
one
virus
list
tabl
includ
studi
approv
relev
ethic
committe
marseil
franc
obtain
investig
benefit
use
phage
spike
individu
consent
patient
requir
sinc
french
nation
regul
term
biomed
research
loi
loi
indic
signatur
hospit
entranc
offic
warrant
sampl
taken
hospit
diagnost
purpos
access
research
exclud
human
genet
research
without
specif
consent
patient
volum
clinic
specimen
spike
accord
procedur
describ
extract
perform
onto
magna
pure
lc
instrument
roch
use
high
pure
viral
nucleic
acid
kit
dna
extract
magna
pure
lc
rna
isol
high
perform
kit
rna
extract
accord
manufactur
recommend
csf
amniot
fluid
biopsi
tissu
effus
aqueou
humor
process
dnarna
extract
use
biorobot
viru
mini
kit
qiagen
revers
transcript
perform
rna
virus
use
taqman
revers
transcript
reagent
kit
roch
random
hexanucleotid
per
manufactur
instruct
specimen
rtpcr
reaction
carri
accord
medic
prescript
tabl
ii
distinct
rtpcr
reaction
detect
perform
reaction
format
mastermix
pmol
primer
pmol
probe
standard
cycl
protocol
min
min
cycl
sec
min
seri
mean
ct
valu
standard
deviat
within
seri
calcul
individu
reaction
subsequ
analys
follow
detect
ev
cmv
serial
dilut
supernat
cell
cultur
media
seri
posit
clinic
sampl
spike
mix
perform
comparison
ct
valu
show
neither
addit
phage
mix
wilcoxon
test
p
cmv
ev
presenc
phagespecif
primer
probe
reaction
mix
wilcoxon
test
p
cmv
ev
interfer
ct
valu
associ
viral
detect
twostep
tabl
onestep
rtpcr
period
studi
clinic
sampl
spike
phage
test
presenc
dna
virus
presenc
rna
virus
correspond
total
result
transmit
prescrib
see
detail
figur
inhibitor
could
detect
type
sampl
highli
variabl
rate
analysi
perform
seri
includ
minimum
sampl
less
case
pleural
effus
sputum
sampl
genit
pharynx
swab
lymph
node
placenta
edta
whole
blood
white
blood
cell
sera
biopsi
pericardi
periton
effus
bronchial
aspir
csf
amniot
fluid
other
swab
urin
aqueou
humor
cultur
cell
plasma
bal
stool
heparin
plasma
bone
marrow
idp
significantli
frequent
detect
rna
dna
plasma
bal
csf
sampl
p
test
yate
correct
convers
idp
significantli
frequent
detect
stool
p
test
yate
correct
final
note
clinic
sampl
store
prior
extract
exhibit
idp
rate
lower
rtpcr
rtrtpcr
techniqu
wide
use
molecular
diagnosi
viral
infect
studi
focus
import
qualiti
control
diagnost
assay
propos
simpl
protocol
synthes
specif
extern
control
combin
standard
techniqu
obtain
quantifi
dna
rna
posit
control
importantli
control
design
includ
extrins
sequenc
contain
rare
cut
site
noti
restrict
enzym
provid
simpl
tool
use
adapt
reproduc
amount
posit
control
also
identifi
pcr
contamin
due
carri
posit
control
detect
perform
real
time
amplif
use
specif
probe
figur
follow
gel
analysi
restrict
noti
dreier
et
al
rolf
et
al
gerriet
et
al
previous
evalu
use
ic
test
limit
seri
sera
cerebrospin
fluid
stool
studi
confirm
perform
home
made
test
significantli
improv
use
phagebas
intern
control
importantli
show
control
use
routin
virolog
diagnosi
usabl
varieti
clinic
sampl
clinic
sampl
spike
phage
allow
detect
inhibitor
dna
rna
virus
thirtysix
differ
type
clinic
sampl
test
includ
variou
blood
sampl
cerebrospin
fluid
stool
respiratori
sampl
swab
biopsi
effus
fluid
larg
number
sampl
test
context
hospit
routin
molecular
virolog
laboratori
use
phage
intern
control
prove
extrem
versatil
could
adapt
broad
rang
method
pathogen
valid
pcr
rtpcr
real
time
techniqu
simplex
multiplex
format
case
rtpcr
assay
onestep
twostep
amplif
format
addit
whilst
current
report
reli
probebas
real
time
amplif
techniqu
method
could
also
conveni
adapt
real
time
sybr
green
detect
assay
import
suggest
strategi
includ
phagebas
intern
control
implement
diagnost
laboratori
irrespect
technic
characterist
amplif
method
use
routin
test
experi
simplex
format
strategi
ie
base
test
phage
viral
pathogen
distinct
amplif
reaction
prove
simpl
costeffect
routin
molecular
diagnosi
sinc
requir
specif
develop
multiplex
reaction
reli
uniqu
control
reaction
dna
virus
anoth
rna
virus
studi
identifi
differ
frequenc
inhibitor
accord
natur
clinic
sampl
sampl
csf
sera
pharynx
swab
inhibitor
identifi
dna
rna
viru
detect
respect
valu
unexpectedli
high
impli
signific
number
sampl
result
believ
neg
absenc
intern
control
consid
unresolv
specif
sampl
heparin
blood
inhibitor
dna
viru
detect
bone
marrow
inhibitor
dna
viru
detect
stool
inhibitor
dna
rna
virus
detect
respect
may
also
benefit
detect
inhibitor
identif
unresolv
test
note
frequenc
amplif
inhibit
relat
natur
sampl
test
also
intrins
link
technic
protocol
use
extract
amplif
nucleic
acid
experi
major
differ
observ
differ
silica
column
magnet
bead
base
extract
techniqu
differ
commerci
pcr
rtpcr
kit
test
data
shown
howev
detail
analysi
may
reveal
specif
techniqu
give
better
result
use
test
specif
sampl
suggest
futur
phagebas
intern
control
may
constitut
costeffect
tool
measur
frequenc
amplif
inhibit
specif
sampl
estim
paramet
may
becom
major
criterion
evalu
extract
lesser
extent
amplif
techniqu
final
context
diagnost
virolog
laboratori
studi
show
standard
extract
amplif
techniqu
use
molecular
diagnosi
human
pathogen
led
signific
proport
unresolv
result
identifi
intern
control
use
absenc
intern
control
sampl
commonli
identifi
neg
hindsight
incorrect
hand
detect
amplif
inhibit
use
phage
intern
control
test
tenfold
dilut
nucleic
acid
extract
demonstr
sampl
actual
posit
costeffect
conveni
strategi
therefor
use
enhanc
qualiti
routin
molecular
diagnosi
may
also
adapt
context
test
larg
number
anim
environment
sampl
